Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity
- Resource Type
- article
- Source
- Frontiers in Pharmacology, Vol 14 (2023)
- Subject
osteoclast NFATc1 ROS rhaponticin bone Therapeutics. Pharmacology RM1-950 - Language
- English
- ISSN
- 1663-9812